Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-10.29	12.84	14.31
Graham Fair Price	7.74	8.63	8.01
PEG	-14.33	0.56	0.65
Price/Book	-17.00	0.71	0.86
Price/Cash Flow	-20.17	-24.25	30.38
Prices/Earnings	-23.51	6.00	7.85
Price/Sales	-12.49	1.63	1.86
Price/FCF	-20.17	-24.25	30.38
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	216.12	0.66	0.21
Operating Margin	18.57	0.11	0.09
ROA	5.03	< 0.005	< 0.005
ROE	0.03	0.03	8.51
ROIC	0.02	0.02	-7.69
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.16	0.13	24.60
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.11	0.16	51.61
EPS QOQ	0.12	0.11	-10.71
FCF QOQ	-0.28	-2.08	-643.64
Revenue QOQ	< 0.005	-0.02	478.09
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	11.89	32.71	175.22
Days Sales Outstanding (DSO)	61.83	75.04	21.36
Inventory Turnover	7.57	2.75	-63.67
Debt/Capitalization	0.55	0.59	7.59
Quick Ratio	0.58	0.73	27.18
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.23	10.58	3.43
Cash	2.22	3.02	35.90
Capex	-1.10	-1.22	-11.59
Free Cash Flow	0.29	-0.31	7.53
Revenue	4.72	4.63	-1.90
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.73	0.98	34.93
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.92	7.70	-2.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating